Cochrane Evidence Synthesis and Methods ►

Anti-herpesvirus prophylaxis versus placebo, no treatment or pre-emptive treatment in hemato-oncological malignancies

We will assess the effects of anti-herpes drugs in hemato-oncological patients comparing prophylaxis versus placebo, no treatment or pre-emptive treatment.

This is a protocol.

Health topics:

Blood disorders > Haematological malignancies > Supportive care

Published:

18 March 2017

Authors:

Beyar Katz O, Bitterman R, Zuckerman T, Ofran Y, Yahav D, Leibovici L, Paul M

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Beyar Katz O, Bitterman R, Zuckerman T, Ofran Y, Yahav D, Leibovici L, Paul M. Anti-herpesvirus prophylaxis versus placebo, no treatment or pre-emptive treatment in hemato-oncological malignancies. Cochrane Database of Systematic Reviews 2017, Issue 3. Art. No.: CD012601. DOI: 10.1002/14651858.CD012601